Lipoic acid

硫辛酸

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameLipoic acid
Drug Alias NameThioctic acidThioctacidThioctic-Acidalpha-Lipoic acidarlipoic acid +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate dehydrogenase kinase stimulants
TargetsPyruvate dehydrogenase kinase
Therapy Area/IndicationsSolid tumoursSchizophreniaDrug-Related Side Effects and Adverse Reactions +[30] 
Global Approved IndicationsDiabetic NeuropathiesLeigh DiseaseLabyrinth Diseases
Approved Indications in ChinaDiabetic Neuropathies
Original Approved Country/TerritoryGermany
Original Approved Date1966/01/01
Country/TerritoryCanadaUnited StatesSweden +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBukwang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKobayashi Kako Co LtdStadapharm GmbhMinia University +[10] 
Inactive CompaniesAugusta UniversityOregon Health And Science UniversityNational Center For Complementary And Integrative Health +[10] 
Active IndicationsSchizophreniaDrug-Related Side Effects and Adverse ReactionsDiabetes Mellitus, Type 1 +[13] 
Inactive IndicationsSolid tumoursObesityHypercholesterolemia +[17] 

Other Information

ATC CodeA10B
Related LinksWikipediaDrugBank